Cargando…
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2
SIMPLE SUMMARY: Despite being in use for almost 50 years, monoclonal antibodies face limitations in their implementation in clinical practice, particularly in pediatrics and pediatric cancer. Although technological advancements and research into new therapeutic targets have led to the development of...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378537/ https://www.ncbi.nlm.nih.gov/pubmed/37509390 http://dx.doi.org/10.3390/cancers15143729 |